Skip to main content
Caplight Logo









Lexie Hearing

Lexie Hearing

Private
San Jose, CaliforniaHealthcare & Life Scienceshttps://lexiehearing.com/us

Last Round

Private Equity

Mar 31, 2025

Total Funding Raised

$111.6M

Company Overview

Lexie Hearing is a health technology company that provides affordable, FDA-cleared over-the-counter hearing aids and remote hearing care solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Consumer Electronics, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

OTC hearing aidsover-the-counter hearing aidsdirect-to-consumer hearing aidshearing healthcarehearing screeningself-fitting hearing aidsDTC hearing aidssmart hearing aidsFDA-cleared hearing aidsdigital audiologyremote hearing supporthearing loss solutionshearableshealth IoTmedical devices

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lexie Hearing Comparables

Compare Lexie Hearing with similar companies based on industry and business-model similarity.

Lexie Hearing comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MDHearing
93%
Eargo
91%
听象科技 (ELEHEAR)
89%

Lexie Hearing Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 31, 2025
Series AFeb 14, 2021
VC RoundDec 1, 2019
SeedJul 1, 2017

Key People

Founding team and executive leadership

Daevon Lexie

Chief Executive Officer

Executive Team

Lexie Hearing Investors

Notable investors and investment history

Lexie Hearing investors
InvestorRounds
Bose VenturesVC Round, Series A
FuturegrowthSeries A
Patient Square CapitalPrivate Equity
HAVAÍCVC Round, Series A
Sphere HoldingsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 23, 2026

    Monthly visitors increased 38% MoM.

  • Mar 31, 2025

    $100M round led by Patient Square Capital.

Lexie Hearing Filings

Explore SEC and related filing metadata, where available.

Lexie Hearing filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lexie Hearing's valuation, stock price, and market status.

Is Lexie Hearing a public or private company?

Lexie Hearing is a private company.

What is the current stock price of Lexie Hearing?

Lexie Hearing is a private company with no public stock price. No recent secondary market data is available.

How much is Lexie Hearing worth (valuation)?

Valuation information for Lexie Hearing is not publicly available.

Can I buy Lexie Hearing stock?

Lexie Hearing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lexie Hearing's last funding round?

Lexie Hearing's most recent funding round was Private Equity on March 31, 2025.

Who are the main investors in Lexie Hearing?

Key investors in Lexie Hearing include Bose Ventures, Patient Square Capital.

Will Lexie Hearing IPO soon?

No public IPO plans have been announced for Lexie Hearing.

How can I track Lexie Hearing secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lexie Hearing's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Jose, California
Employee Range26
Year Founded2020
Last FundingMar 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?